| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |